Audited Results of Bliss GVS Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	729.81	667.20	605.46	598.34	636.36
Manufacturing Expenses	12.95	9.76	8.81	5.80	7.09
Personnel Expenses	121.50	99.42	82.59	72.54	65.06
Selling Expenses	1.67	1.61	0.99	0.50	0.14
Administrative Expenses	117.02	118.73	106.43	114.45	110.92
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	595.77	575.62	498.29	508.18	527.16
Operating Profit	134.03	91.59	107.17	90.16	109.20
Other Recurring Income	43.72	36.22	33.50	50.77	32.63
Adjusted PBDIT	177.75	127.80	140.67	140.92	141.83
Financial Expenses	11.11	6.58	5.81	10.06	4.32
Depreciation	31.02	27.05	23.52	15.17	13.85
Other Write offs	0	0	0	0	0
Adjusted PBT	135.62	94.17	111.34	115.69	123.66
Tax Charges	36.59	25.20	19.61	30.21	33.74
Adjusted PAT	99.03	68.97	91.73	85.48	89.92
Non Recurring Items	-2.34	-0.56	-41.24	-0.67	3.05
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	96.87	68.97	50.64	85.48	92.66
Equity Dividend	10.56	5.25	5.21	5.19	5.18
Preference Dividend	0	0	0	0	0
Retained Earnings	1,042.99	955.74	891.46	844.96	764.02

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article